Quirk Erin - Insider Non-Derivative Transactions at Terns Pharmaceuticals, Inc. (TERN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 23, 2024, Quirk Erin's relationship to Terns Pharmaceuticals, Inc. (TERN) is Officer (President, Head of R&D), and currently has 75,000 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other TERN insiders.
Data Source: SEC.
Quirk Erin - Insider Non-Derivative Transactions at TERN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 24, 2024 | Acquisition -- (Common Stock) | 75000 | 0 | 75000 |